Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M J Khandekar"'
Autor:
M Protani, D C Greenwood, P Cohen, N Keum, K Decorby, Caroline O. Terranova, D H Lee, J H Martin, M M Reeves, A Schienkiewitz, Annie S. Anderson, Teresa Norat, S Engel, M J Khandekar, F. Streckmann, A Mirsoian, H J Senn, M Dobbins, Ian J. Douglas, T Effertz, N R Foster, W J Murphy, Harriet Forbes, G Yothers, T J Key, D Grapov, K S Courneya, M Coory, R L Sedjo, J Baselga, F Verheyen, G B Mensink, M Haftenberger, D B Liesenfeld, P P Fahey, E G Eakin, B. C. K. Choi, T Byers, B S Cheema, S L Kilbreath, J A Ligibel, J F Fahrmann, F A Sinicrope, A. Will, B M Spiegelman, C M Alfano, K Bhaskaran, N. Bergenthal
Publikováno v:
Geburtshilfe und Frauenheilkunde. 77:227-229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c699c59328f99f8ee06b5b3cc319a83f
https://doi.org/10.1055/s-0042-121992
https://doi.org/10.1055/s-0042-121992
Publikováno v:
Catheterization and Cardiovascular Diagnosis. 38:325-330
Thrombolytic agents are used to restore coronary artery perfusion and limit the size of a myocardial infarction. The systemic effects of these drugs, streptokinase (SK), urokinase (UK), and recombinant tissue plasminogen activator (rtPA), have been s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee31ac095f5892843827cd874fae5a8a
https://doi.org/10.1002/(sici)1097-0304(199607)38:3<325::aid-ccd25>3.0.co
https://doi.org/10.1002/(sici)1097-0304(199607)38:3<325::aid-ccd25>3.0.co
Publikováno v:
Catheterization and cardiovascular diagnosis. 38(3)
Thrombolytic agents are used to restore coronary artery perfusion and limit the size of a myocardial infarction. The systemic effects of these drugs, streptokinase (SK), urokinase (UK), and recombinant tissue plasminogen activator (rtPA), have been s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c73bb4858f469aee84554a4fc2446897
https://pubmed.ncbi.nlm.nih.gov/8804773
https://pubmed.ncbi.nlm.nih.gov/8804773